Toregem BioPharma and WuXi Biologics to partner for antibody development
Pharmaceutical Technology
OCTOBER 12, 2022
As part of the collaboration, Toregem will use WuXi Biologics’ integrated CMC services in cell culture development, cell line development, bioassay development, biologics GMP manufacturing, cell banking and testing services, as well as other related services.
Let's personalize your content